ICON plc (NASDAQ:ICLR), a leading global provider of outsourced drug and device development and commercialization services with an adjusted market capitalization of $13.8 billion, faces a complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback